Since HA content is increased during breast cancer progression and elevations in HAS2 and HA correlate with poor prognosis, further studies to evaluate the association of vitamin D signaling and the HA pathway in aggressive human breast cancers are of significant interest. This evidence concerns the gene HAS2 and breast cancer.